Our work is focused on discovering cures for specific cancers and debilitating diseases. This has led us toward developing a range of combination devices in the areas of therapeutic and regenerative medicine that advance both the science and treatment options available to patients. All of the pipeline products described here are past the initial development cycle and are in various stages of clinical trials.
There are 7,000 types of rare diseases
95% of them lack any FDA approved treatment. Our work is imperative to the quality of life for more than 5% of the world’s population.